Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 1, 2012, Pages 68-78

  Bibova, Ilona ^a,b   Linhartova, Irena ^a   Stanek, Ondrej ^a,b   Rusnakova, Vendula ^c   Kubista, Mikael ^c,d   Suchanek, Miloslav ^b   Vasakova, Martina ^e   Sebo, Peter ^a,c  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^d TATAA Biocenter   (Sweden)

^e FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

Author keywords

Blood sample processing; Latent tuberculosis infection; QPCR; Reference gene

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; MYCOBACTERIUM ANTIGEN;

ADULT; AGED; ARTICLE; BACTERIAL IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; MALE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LATENT TUBERCULOSIS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 83055184165     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.09.024     Document Type: Article

References (41)

1. Abramo C., Meijgaarden K.E., Garcia D., Franken K.L., Klein M.R., Kolk A.J., Oliveira S.C., Ottenhoff T.H., Teixeira H.C. Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect. 2006, 8:45-51.
2. Agranoff D., Fernandez-Reyes D., Papadopoulos M.C., Rojas S.A., Herbster M., Loosemore A., Tarelli E., Sheldon J., Schwenk A., Pollok R., Rayner C.F., Krishna S. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368:1012-1021.
3. Ameixa C., Friedland J.S. Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13. Infect. Immun. 2001, 69:2470-2476.
4. Andersen C.L., Jensen J.L., Orntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64:5245-5250.
5. Azzurri A., Sow O.Y., Amedei A., Bah B., Diallo S., Peri G., Benagiano M., D'Elios M.M., Mantovani A., Del Prete G. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005, 7:1-8.
6. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., Quinn C., Blankenship D., Dhawan R., Cush J.J., Mejias A., Ramilo O., Kon O.M., Pascual V., Banchereau J., Chaussabel D., O'Garra A. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
7. Biselli R., Mariotti S., Sargentini V., Sauzullo I., Lastilla M., Mengoni F., Vanini V., Girardi E., Goletti D., D'Amelio R., Nisini R. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin. Microbiol. Infect. 2010, 16:1282-1284.
8. Bland J.M., Altman D.G. Multiple significance tests: the Bonferroni method. BMJ 1995, 310:170.
9. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A, (2004) Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37:112-114, 116, 118-119.
10. Fiorenza G., Rateni L., Farroni M.A., Bogue C., Dlugovitzky D.G. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol. Lett. 2005, 98:45-48.
11. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 2005, 6:1142-1151.
12. Frahm M., Goswami N.D., Owzar K., Hecker E., Mosher A., Cadogan E., Nahid P., Ferrari G., Stout J.E. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 2011, 91:250-256.
13. Hernandez-Pando R., Orozco H., Aguilar D. Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp (Warsz) 2009, 57:355-367.
14. Jamil B., Shahid F., Hasan Z., Nasir N., Razzaki T., Dawood G., Hussain R. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 2007, 87:279-287.
15. Jolliffe I.T. Principal component analysis 2002, Springer, Heidelberg.
16. Karge W.H., Schaefer E.J., Ordovas J.M. Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol. Biol. 1998, 110:43-61.
17. Kaufmann S.H., McMichael A.J. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat. Med. 2005, 11:S33-S44.
18. Kender J., Capova D., Suchanek M. Krajiny Ceska republiky v zrcale statistiky 2003, 15-18. Ceska geologick sluzba, Praha, Czech Republic.
19. Krejsek J., Kopecky O. Klinicka imunologie 2004, Nucleus HK, Hradec Kralove, Czech Republic.
20. Kroesen S., Widmer A.F., Tyndall A., Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 2003, 42:617-621.
21. Kubista M., Andrade J.M., Bengtsson M., Forootan A., Jonak J., Lind K., Sindelka R., Sjoback R., Sjogreen B., Strombom L., Stahlberg A., Zoric N. The real-time polymerase chain reaction. Mol. Aspects Med. 2006, 27:95-125.
22. Lefever S., Hellemans J., Pattyn F., Przybylski D.R., Taylor C., Geurts R., Untergasser A., Vandesompele J. RDML: structured language and reporting guidelines for real-time quantitative PCR data. Nucleic Acids Res. 2009, 37:2065-2069.
23. Li Y.L., Ye F., Hu Y., Lu W.G., Xie X. Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction. Anal. Biochem. 2009, 394:110-116.
24. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104:1598-1603.
25. Marino S., Sud D., Plessner H., Lin P.L., Chan J., Flynn J.L., Kirschner D.E. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue. PLoS Comput. Biol. 2007, 3:1909-1924.
26. Mazurek G.H., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm. Rep. 2010, 59:1-25.
27. Menzies D., Al Jahdali H., Al Otaibi B. Recent developments in treatment of latent tuberculosis infection. Indian J. Med. Res. 2011, 133:257-266.
28. Oberbach A., Schlichting N., Bluher M., Kovacs P., Till H., Stolzenburg J.U., Neuhaus J. Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS One 2010, 5:e10882.
29. Pai M., Riley L.W., Colford J.M. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 2004, 4:761-776.
30. Rasmussen R. Quantification on the LightCycler. Rapid cycle real-time PCR 2001, 21-34. Springer, Heidelberg. S. Meuer, C. Wittwer, K. Nakagawara (Eds.).
31. Ray J.C., Flynn J.L., Kirschner D.E. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 2009, 182:3706-3717.
32. Ruhwald M., Bjerregaard-Andersen M., Rabna P., Kofoed K., Eugen-Olsen J., Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect. 2007, 9:806-812.
33. Schluger N.W., Rom W.N. The host immune response to tuberculosis. Am. J. Respir. Crit. Care Med. 1998, 157:679-691.
34. Stamova B.S., Apperson M., Walker W.L., Tian Y., Xu H., Adamczy P., Zhan X., Liu D.Z., Ander B.P., Liao I.H., Gregg J.P., Turner R.J., Jickling G., Lit L., Sharp F.R. Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med. Genomics 2009, 2:49.
35. Tichopad A., Kitchen R., Riedmaier I., Becker C., Stahlberg A., Kubista M. Design and optimization of reverse-transcription quantitative PCR experiments. Clin. Chem. 2009, 55:1816-1823.
36. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. research0034.1-research0034.11.
37. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 2003, 112:1437-1443.
38. Whittaker E., Gordon A., Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?. PLoS One 2008, 3:e3901.
39. World Health Organization Global tuberculosis control report, WHO/HTM/TB/2010.7 2010, World Health Organization, Geneva, Switzerland.
40. Wu B., Huang C., Kato-Maeda M., Hopewell P.C., Daley C.L., Krensky A.M., Clayberger C. Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J. Immunol. 2007, 178:3688-3694.
41. Yamada G., Shijubo N., Shigehara K., Okamura H., Kurimoto M., Abe S. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am. J. Respir. Crit. Care Med. 2000, 161:1786-1789.